Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome

Tourette Syndrome (TS) is a complex neurodevelopmental disorder characterized by vocal and motor tics lasting more than a year. It is highly polygenic in nature with both rare and common previously associated variants. Epidemiological studies have shown TS to be correlated with other phenotypes, but large-scale phenome wide analyses in biobank level data have not been performed to date. In this study, we used the summary statistics from the latest meta-analysis of TS to calculate the polygenic risk score (PRS) of individuals in the UK Biobank data and applied a Phenome Wide Association Study (PheWAS) approach to determine the association of disease risk with a wide range of phenotypes. A total of 57 traits were found to be significantly associated with TS polygenic risk, including multiple psychosocial factors and mental health conditions such as anxiety disorder and depression. Additional associations were observed with complex non-psychiatric disorders such as Type 2 diabetes, heart palpitations, and respiratory conditions. Cross-disorder comparisons of phenotypic associations with genetic risk for other childhood-onset disorders (e.g.: attention deficit hyperactivity disorder [ADHD], autism spectrum disorder [ASD], and obsessive-compulsive disorder [OCD]) indicated an overlap in associations between TS and these disorders. ADHD and ASD had a similar direction of effect with TS while OCD had an opposite direction of effect for all traits except mental health factors. Sex-specific PheWAS analysis identified differences in the associations with TS genetic risk between males and females. Type 2 diabetes and heart palpitations were significantly associated with TS risk in males but not in females, whereas diseases of the respiratory system were associated with TS risk in females but not in males. This analysis provides further evidence of shared genetic and phenotypic architecture of different complex disorders

Meta-Analysis of Tourette Syndrome and Attention Deficit Hyperactivity Disorder Provides Support for a Shared Genetic Basis

Gilles de la Tourette Sydrome (TS) is a childhood onset neurodevelopmental disorder, characterized phenotypically by the presence of multiple motor and vocal tics. It is often accompanied by multiple psychiatric comorbidities, with Attention Deficit/Hyperactivity Disorder (ADHD) among the most common. The extensive co-occurrence of the two disorders suggests a shared genetic background. A major step toward the elucidation of the genetic architecture of TS was undertaken by the first TS Genome-wide Association Study (GWAS) reporting 552 SNPs that were moderately associated with TS (p < 1E-3). Similarly, initial ADHD GWAS attempts and meta-analysis were not able to produce genome-wide significant findings, but have provided insight to the genetic basis of the disorder. Here, we examine the common genetic background of the two neuropsychiatric phenotypes, by meta-analyzing the 552 top hits in the TS GWAS with the results of ADHD first GWASs. We identify 19 significant SNPs, with the top four implicated genes being TBC1D7, GUCY1A3, RAP1GDS1, and CHST11. TBCD17 harbors the top scoring SNP, rs1866863 (p:3.23E-07), located in a regulatory region downstream of the gene, and the third best-scoring SNP, rs2458304 (p:2.54E-06), located within an intron of the gene. Both variants were in linkage disequilibrium with eQTL rs499818, indicating a role in the expression levels of the gene. TBC1D7 is the third subunit of the TSC1/TSC2 complex, an inhibitor of the mTOR signaling pathway, with a central role in cell growth and autophagy. The top genes implicated by our study indicate a complex and intricate interplay between them, warranting further investigation into a possibly shared etiological mechanism for TS and ADHD

Tourette syndrome research highlights from 2022

This is the ninth yearly article in the Tourette Syndrome Research Highlights series, summarizing selected research reports from 2022 relevant to Tourette syndrome. The authors briefly summarize reports they consider most important or interesting

Tourette syndrome research highlights from 2022 [version 1; peer review: 2 approved, 1 approved with reservations]

This is the ninth yearly article in the Tourette Syndrome Research Highlights series, summarizing selected research reports from 2022 relevant to Tourette syndrome. The authors briefly summarize reports they consider most important or interesting

Unraveling the Genetic Background of Complex Disorders - Methodology and Discoveries

Complex disorders are caused by multiple genetic, environmental, and lifestyle factors, and their interactions. Most human diseases are complex, including many psychiatric, autoimmune, neurodegenerative, and cardiovascular disorders. Understanding their genetic background is an essential step toward developing effective preventive and therapeutic interventions for these disorders. In this dissertation, we present an overview of state-of-the-art methodology that is used to help elucidate the genetic basis of complex diseases and apply these methods to understand the genetic background of different complex disorders. First, we carried out a GWAS for myasthenia gravis (MG), a rare autoimmune disorder, and detected a novel risk locus, AGRN, which encodes a protein, involved in neuromuscular junction activation. Additionally, we observed significant genetic correlation between MG and ADs, and variants with pleiotropic effects. Second, we explored the genetic and phenotypic relationships among 11 different autoimmune disorders (ADs), using GWAS results o to calculate polygenic risk scores (PRS) and performing a PRS- phenomewide association study (PheWAS) analysis with 3,281 phenotypes available in the UK Biobank. We observed associations of ADs PRS with phenotypes in multiple categories, including lifestyle, biomarkers, mental and physical health. We also explored the shared genetic components among the ADs, through genetic correlation and cross-disorder meta-analysis approaches, where we identified pleiotropic variants among the correlated ADs. Finally, we performed a meta-analysis GWAS of Tourette Syndrome (TS) followed by post-GWAS analyses including biological annotation of the results, and association tests of TS PRS with brain volumes. We detected a novel locus, NR2F1, associated with TS, supported by eQTL and Hi-C data. TS PRS was significantly associated with right and left thalamus volumes and right putamen volume. Overall, our work demonstrates the power of GWAS and related methods to help disentangle the genetic basis of complex disease and provides important insights into the genetic basis of the specific disorders that are the focus of our studies

dissertation.pdf

Complex disorders are caused by multiple genetic, environmental, and lifestyle factors, and their interactions. Most human diseases are complex, including many psychiatric, autoimmune, neurodegenerative, and cardiovascular disorders. Understanding their genetic background is an essential step toward developing effective preventive and therapeutic interventions for these disorders. In this dissertation, we present an overview of state-of-the-art methodology that is used to help elucidate the genetic basis of complex diseases and apply these methods to understand the genetic background of different complex disorders. First, we carried out a GWAS for myasthenia gravis (MG), a rare autoimmune disorder, and detected a novel risk locus, AGRN, which encodes a protein, involved in neuromuscular junction activation. Additionally, we observed significant genetic correlation between MG and ADs, and variants with pleiotropic effects. Second, we explored the genetic and phenotypic relationships among 11 different autoimmune disorders (ADs), using GWAS results o to calculate polygenic risk scores (PRS) and performing a PRS- phenome-wide association study (PheWAS) analysis with 3,281 phenotypes available in the UK Biobank. We observed associations of ADs PRS with phenotypes in multiple categories, including lifestyle, biomarkers, mental and physical health. We also explored the shared genetic components among the ADs, through genetic correlation and cross-disorder meta-analysis approaches, where we identified pleiotropic variants among the correlated ADs. Finally, we performed a meta-analysis GWAS of Tourette Syndrome (TS) followed by post-GWAS analyses including biological annotation of the results, and association tests of TS PRS with brain volumes. We detected a novel locus, NR2F1, associated with TS, supported by eQTL and Hi-C data. TS PRS was significantly associated with right and left thalamus volumes and right putamen volume. Overall, our work demonstrates the power of GWAS and related methods to help disentangle the genetic basis of complex disease and provides important insights into the genetic basis of the specific disorders that are the focus of our studies.</p

Genome-wide Association Study points to novel locus for Gilles de la Tourette Syndrome

Background: Tourette Syndrome (TS) is a childhood-onset neurodevelopmental disorder of complex genetic architecture, characterized by multiple motor tics and at least one vocal tic persisting for more than one year. Methods: We performed a genome-wide meta-analysis integrating a novel TS cohort with previously published data, resulting in a sample size of 6,133 TS individuals and 13,565 ancestry-matched controls. Results: We identified a genome-wide significant locus on chromosome 5q15. Integration of eQTL, Hi-C and GWAS data implicated the NR2F1 gene and associated lncRNAs within the 5q15 locus. Heritability partitioning identified statistically significant enrichment in brain tissue histone marks, while polygenic risk scoring on brain volume data identified statistically significant associations with right and left thalamus volumes and right putamen volume. Conclusions: Our work presents novel insights in the neurobiology of TS opening up new directions for future studies

Genome-wide Association Study identifies two novel loci for Gilles de la Tourette Syndrome

Tourette Syndrome (TS) is a childhood-onset neurodevelopmental disorder of complex genetic architecture, characterized by multiple motor tics and at least one vocal tic persisting for more than one year. We performed a genome-wide meta-analysis integrating a novel TS cohort with previously published data, resulting in a sample size of 6,133 TS individuals and 13,565 ancestry-matched controls. We identified a genome-wide significant locus on chromosome 5q15 and one array-wide significant locus on chromosome 2q24.2. Integration of eQTL, Hi-C and GWAS data implicated the NR2F1 gene and associated lncRNAs within the 5q15 locus, and the RBMS1 gene within the 2q24.2 locus. Polygenic risk scoring using previous GWAS results demonstrated statistically significant ability to predict TS status in the novel cohort. Heritability partitioning identified statistically significant enrichment in brain tissue histone marks, while polygenic risk scoring on brain volume data identified statistically significant associations with right and left putamen volumes. Our work presents novel insights in the neurobiology of TS opening up new directions for future studies

Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome

Tourette Syndrome (TS) is a complex neurodevelopmental disorder characterized by vocal and motor tics lasting more than a year. It is highly polygenic in nature with both rare and common previously associated variants. Epidemiological studies have shown TS to be correlated with other phenotypes, but large-scale phenome wide analyses in biobank level data have not been performed to date. In this study, we used the summary statistics from the latest meta-analysis of TS to calculate the polygenic risk score (PRS) of individuals in the UK Biobank data and applied a Phenome Wide Association Study (PheWAS) approach to determine the association of disease risk with a wide range of phenotypes. A total of 57 traits were found to be significantly associated with TS polygenic risk, including multiple psychosocial factors and mental health conditions such as anxiety disorder and depression. Additional associations were observed with complex non-psychiatric disorders such as Type 2 diabetes, heart palpitations, and respiratory conditions. Cross-disorder comparisons of phenotypic associations with genetic risk for other childhood-onset disorders (e.g.: attention deficit hyperactivity disorder [ADHD], autism spectrum disorder [ASD], and obsessive-compulsive disorder [OCD]) indicated an overlap in associations between TS and these disorders. ADHD and ASD had a similar direction of effect with TS while OCD had an opposite direction of effect for all traits except mental health factors. Sex-specific PheWAS analysis identified differences in the associations with TS genetic risk between males and females. Type 2 diabetes and heart palpitations were significantly associated with TS risk in males but not in females, whereas diseases of the respiratory system were associated with TS risk in females but not in males. This analysis provides further evidence of shared genetic and phenotypic architecture of different complex disorders